Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HIK Hikma Pharmaceuticals Plc

1,909.00
55.00 (2.97%)
Last Updated: 14:17:45
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Hikma Pharmaceuticals Plc LSE:HIK London Stock Exchange Ordinary Share GB00B0LCW083 ORD SHS 10P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   55.00 2.97 1,909.00 1,909.00 1,910.00 1,914.00 1,861.00 1861 165,018 13:17:45   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 2.88B 192M 0.8685 21.98 4.22B
 Type  Size  Price  Time  Units 
  1,392 1,908.164 13:16:00 GBX
 
Recent News
DateTimeSource
HeadlineMore HIK News
25/04/202414:28LSEG_RNSHikma Pharmaceuticals Plc Result of AGM
25/04/202410:15ALNCHikma Pharmaceuticals backs outlook after making strong start to 2024
25/04/202410:15ALNCHikma Pharmaceuticals backs outlook after making strong start to 2024
25/04/202407:00LSEG_RNSHikma Pharmaceuticals Plc Trading Statement
17/04/202410:42LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
15/04/202416:43LSEG_RNSHikma Pharmaceuticals Plc Hikma appoints new President of Generics business
11/04/202410:58LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
26/04/202410:00PBBHikma Pharmaceuticals1,766
13/01/201515:12PBB *** Hikma ***99
Data Downloads for HIK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Hikma Pharmaceuticals Plc
Get quick technical analysis for Hikma Pharmaceuticals Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Hikma Pharmaceuticals Plc Articles